The Complete Guide to NAD+ and NMN for Anti-Aging (2026)

Photo by Logan Voss on Unsplash

By The Longevity Dose Editorial Team · Evidence-reviewed · Last updated September 2026

NAD+ and aging are linked in one of the most researched areas of modern longevity science: as NAD+ falls with age, so does the function of nearly every system that keeps you healthy, from DNA repair to energy metabolism to immune defense. Dr. David Sinclair at Harvard has publicly described NAD+ decline as a central driver of aging, and human clinical trials now confirm that the precursors NMN and NR raise NAD+ in people. But the honest reality in 2026 is that the evidence is both genuinely exciting and genuinely incomplete, which is a big part of why plenty of people try these supplements and then quit. This guide walks through what NAD+ is, what the human trials actually show, why people stop, and how to make a smart decision for yourself.

What Is NAD+ and Why Does It Matter?

NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme found in every cell in your body and is involved in hundreds of enzymatic reactions. Think of it as one of your cellular system’s essential operating molecules. Without adequate NAD+, your cells cannot produce energy efficiently, repair broken DNA, or regulate inflammation properly.

Three major classes of proteins depend heavily on NAD+. Sirtuins (SIRT1 to SIRT7) regulate gene expression, DNA repair, and metabolic health. PARPs (poly ADP-ribose polymerases) are your primary DNA repair enzymes. CD38 is an enzyme involved in immune function that becomes a major NAD+ consumer as you age. All three systems draw on the same NAD+ pool, so when supply drops, everything competes.

The Sirtuin Connection

Sirtuins earned the nickname “longevity genes” partly because research from Dr. Sinclair’s lab and others showed that activating them extends lifespan in yeast, worms, flies, and mice. SIRT1 in particular regulates mitochondrial biogenesis, inflammation, and cellular stress resistance. But sirtuins only work when NAD+ is available, which is why NAD+ sits at the center of so much longevity research today.

PARP1, your busiest DNA repair enzyme, can consume large amounts of NAD+ during periods of high DNA damage. As you age and accumulate more DNA damage, PARP1 activity rises, draining NAD+ further. It is a compounding problem, and one reason NAD+ restoration is considered a plausible therapeutic target by researchers at the NIH National Institute on Aging.

How NAD+ Declines With Age

NAD+ levels in human and animal tissue fall substantially with age. The decline is not a trivial biochemical footnote. Lower NAD+ means your mitochondria produce less energy, which contributes to the fatigue and reduced exercise capacity many people notice in middle age. Lower NAD+ means slower DNA repair, which over decades increases the accumulation of genetic errors. And lower NAD+ impairs sirtuin activity, which disrupts the epigenetic regulation that keeps your genes expressing properly. For more on how scientists measure that drift, see our guide on what epigenetic clocks measure.

NAD+ and Cellular Senescence

There is also a meaningful link between NAD+ depletion and senescent cells, the so-called zombie cells that stop dividing but do not die and instead secrete inflammatory molecules that damage surrounding tissue. CD38, which ramps up in senescent immune cells, is a primary NAD+-consuming enzyme, so as senescent cells accumulate, CD38 activity rises and NAD+ depletion accelerates. You can read more about how researchers target these cells in our post on senolytics and zombie cells.

The practical takeaway: NAD+ decline is not one isolated aging problem. It is a cascade that touches energy production, DNA integrity, inflammation, and cellular cleanup, which is why it draws serious research attention.

NMN vs. NR: The Two Main Precursors

Your body cannot efficiently absorb NAD+ directly from a supplement, so researchers focus on precursors, compounds your cells convert into NAD+. The two most studied are NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Both come from the vitamin B3 family, and both have been shown in human trials to raise blood NAD+.

How They Differ

NMN is one step closer to NAD+ in the biosynthesis pathway than NR: your cells convert NMN to NAD+ via the enzyme NMNAT. NR must first be converted to NMN, adding one conversion step, though this does not appear to meaningfully limit its ability to raise systemic NAD+. NR has a slightly longer human research track record; NMN tends to cost more per gram. For a full head-to-head, see our detailed breakdown: NMN vs. NR: which NAD+ booster actually works?

What the Human Trials Actually Show (2026)

Here is where we have to be straight with you. The human evidence for NAD+ precursors is genuinely promising but not yet proof of an anti-aging benefit. The trials so far have established safety, confirmed that these supplements raise NAD+ in people, and shown improvements in some biomarkers. What they have not shown is that raising NAD+ slows aging or extends healthy lifespan in humans. The table below summarizes the landmark human trials so you can see the actual designs and findings.

How to read this table: the consistent, replicated finding is that both precursors raise NAD+ and are well tolerated. The functional benefits (insulin sensitivity, muscle, blood pressure, gait) show up in some trials but are modest, sometimes only nominally significant, and measured over weeks in small groups. No trial has tested whether NAD+ precursors extend human lifespan or healthspan, because those studies take years. The TAME trial for metformin, which you can read about in our metformin longevity evidence review, is a good reminder of how long definitive human aging data takes to arrive. For where NAD+ precursors rank against other options, see our longevity supplement stack comparison.

Evidence rating: promising but limited. Multiple human RCTs confirm NAD+ elevation and good safety. Some functional improvements have been observed. No long-term human lifespan or healthspan data exists yet.

Why Do People Stop Taking NMN?

Plenty of people try NMN or NR for a few months and then stop. Searching for why people quit is one of the most common NAD+ questions online, and the reasons are worth understanding before you spend anything.

• You cannot feel it. NAD+ rising in a blood test is not something you notice day to day. The trial benefits are real but modest and measured with instruments, not by how you feel, so many people conclude nothing is happening and stop.
• Cost adds up. A daily precursor at trial doses runs into real monthly money with no guaranteed payoff, which is a hard sell for an intervention whose long-term benefit is still unproven.
• Regulatory uncertainty. The status of NMN as a dietary supplement in the United States has been under regulatory question, which has at times affected availability and shaken buyer confidence.
• The cancer-metabolism question. Because NAD+ fuels all rapidly dividing cells, some people stop out of caution, especially those with a personal or family cancer history (covered in the risks section below).
• The fundamentals do more. People who compare an NAD+ supplement against dialing in exercise, sleep, and fasting often decide their money and attention are better spent there first.

None of these means the supplement does nothing. They mean the honest value proposition is narrow, and it is reasonable to want proof you can feel before committing long-term.

How to Raise NAD+ Naturally First

Before spending money on NMN or NR, know that several lifestyle interventions raise NAD+ meaningfully, each with mechanistic evidence behind it. Our dedicated guide on how to increase NAD+ naturally covers the sourced detail; here is the short version.

Exercise

Endurance exercise activates AMPK, which stimulates NAD+ biosynthesis through the salvage pathway. Zone 2 cardio in particular improves mitochondrial efficiency and NAD+-dependent sirtuin activity. For the full picture, see our guide on zone 2 training for longevity.

Fasting and Time-Restricted Eating

Fasting shifts the NAD+ to NADH ratio in NAD+’s favor and activates AMPK and sirtuins independently. Our breakdown of fasting protocols for longevity covers which approaches have the most evidence.

Heat Exposure and Diet

Heat stress from sauna use activates heat shock proteins and SIRT1, both NAD+-dependent. On the plate, tryptophan and niacin (vitamin B3) are dietary NAD+ precursors, found in turkey, eggs, dairy, meat, fish, mushrooms, and green vegetables. Food sources do not match a concentrated supplement, but a nutrient-poor diet can worsen NAD+ status even with supplementation.

The Practical Protocol: Doses and Timing

If you have read this far and want to try a precursor, here is what the human trials support. This is not medical advice, it is a summary of what has been used in the studies in the table above.

Dosing

• NMN: 250 mg per day is the dose used in the Yoshino and Igarashi trials that showed measurable NAD+ increases (33888596, 35927255). Human data above that dose is limited, so starting at 250 mg is reasonable.
• NR: human trials have used up to 1,000 mg per day with good tolerability (29599478, 31412242). Easing in at a lower dose before working up is reasonable.

Timing

Morning dosing makes practical sense because NAD+ metabolism follows circadian rhythms and sirtuin activity tends to be higher earlier in the day. You can take it with or without food; both were used in trials without a clear absorption difference reported.

Stack Considerations

Several compounds are often combined with NMN or NR, though the human evidence for the combinations is thin: resveratrol or pterostilbene (sirtuin activators), TMG (added because NMN may increase methyl-group use), and CD38 inhibitors like apigenin or quercetin. If you are newer to this, do not stack everything at once. Start with one precursor for a couple of months and, if you want objective data, consider a biological age test before and after. Our guide to biological age testing explains which tests are worth the money.

Honest Risks and Who Should Be Cautious

NAD+ precursors have a good short-term safety profile in the trials so far, with no serious adverse events attributed to NMN or NR at standard doses. But several real caveats deserve attention.

The Cancer Question

This is the most legitimate concern raised by serious researchers. NAD+ is essential for cancer cell metabolism as much as for healthy cells, and pre-clinical studies have shown that elevated NAD+ can accelerate the growth of tumors already present in animal models. This does not mean NAD+ supplementation causes cancer, but if you have an active cancer diagnosis or a strong family history, this is a conversation to have with your oncologist before supplementing. Dr. Sinclair has acknowledged this concern openly.

Flushing and Drug Interactions

NMN and NR do not typically cause the flushing associated with high-dose niacin, though some people report mild flushing at higher doses that usually fades. They can also theoretically interact with medications affecting DNA repair pathways (such as some chemotherapy agents). If you take prescription medications, particularly for cancer, diabetes, or cardiovascular disease, check with your doctor first.

Rapamycin Interaction

Some researchers have raised the question of whether combining mTOR inhibitors like rapamycin with NAD+ precursors has additive or competing effects. It has not been well studied in humans. If you are in a rapamycin protocol, discuss NAD+ supplementation with the prescribing physician. For background, see our post on rapamycin for longevity.

The Bottom Line

NAD+ decline is real, measurable, and connected to multiple mechanisms of aging. That part of the science is solid. The honest uncertainty is whether supplementing with NMN or NR turns those mechanistic benefits into meaningful, felt improvements in human health and longevity at doses people can realistically take.

Based on the 2026 evidence, an NAD+ precursor is a reasonable choice for health-conscious adults over 40 who have already optimized the fundamentals: consistent exercise, quality sleep, a whole-foods diet, and some form of fasting or caloric moderation. If those are not in place, no supplement will compensate. If they are, and you want a well-studied, low-risk intervention with plausible mechanistic support and some positive human trial data, NMN or NR is among the more defensible choices in the longevity supplement space. It is not magic and it is not useless. It sits in the frustrating middle ground where the science is compelling enough to take seriously but not mature enough to guarantee results, and we would rather tell you that plainly than oversell it.

Affiliate Disclosure: The Longevity Dose may earn a small commission if you purchase through the links below, at no additional cost to you. We only link products and books with a genuine research track record. Learn more.

Sources

• Trammell SAJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948. PMID 27721479.
• Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286. PMID 29599478.
• Elhassan YS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome. Cell Rep. 2019;28(7):1717–1728. PMID 31412242.
• Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. PMID 33888596.
• Brakedal B, et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease. Cell Metab. 2022;34(3):396–407. PMID 35235774.
• Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ and alters muscle function in healthy older men. NPJ Aging. 2022;8:5. PMID 35927255.
• NIH National Institute on Aging. Aging biology and cellular mechanisms resources.

Frequently Asked Questions

What is NAD+ and why does it decline with age?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in hundreds of enzymatic reactions, including DNA repair, energy production, and sirtuin activation. It falls substantially with age, largely because aging increases the activity of NAD+-consuming enzymes like CD38 and PARP1 while biosynthesis slows. That decline is linked to impaired mitochondrial function, slower DNA repair, and increased cellular inflammation.

Does NMN actually increase NAD+ in humans?

Yes. Multiple human clinical trials confirm that oral NMN raises blood NAD+. A trial in aged men found that 250 mg of NMN per day raised NAD+ over 6 to 12 weeks (PMID 35927255), and a Science trial found 250 mg improved muscle insulin sensitivity in prediabetic women (PMID 33888596). Whether those elevated levels produce meaningful anti-aging outcomes is still being investigated.

What is the difference between NMN and NR?

Both are NAD+ precursors from the vitamin B3 family. NMN is one biochemical step closer to NAD+ than NR, but both raise blood NAD+ in human trials. NR has a slightly longer clinical research record; NMN tends to cost more per gram. Neither has been proven to extend human lifespan as of 2026.

Why do people stop taking NMN?

The most common reasons are that the effect is not something you can feel day to day, the ongoing cost, regulatory uncertainty about NMN’s supplement status in the United States, and caution around the cancer-metabolism question. Many people also decide that exercise, sleep, and fasting deserve their attention first, since those have far stronger human evidence.

What dose of NMN should I take?

Human trials have most commonly used 250 mg of NMN per day, which is the dose that showed measurable NAD+ increases and functional benefits in the Yoshino and Igarashi studies (PMID 33888596, PMID 35927255). Human data above that dose is limited, so starting at 250 mg in the morning, with or without food, is a reasonable approach.

Is it safe to take NAD+ supplements long-term?

Published human trials, which have generally run from a few weeks to a few months, report good tolerability and no serious adverse events for NMN and NR at standard doses. Truly long-term safety data in humans does not yet exist, and the main open question is the cancer-metabolism caution described above. If you have an active cancer diagnosis or take prescription medications, talk with your doctor before starting, and revisit the decision periodically rather than assuming indefinite use is proven safe.